# PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FB

> **NCT00527579** · PHASE1 · COMPLETED · sponsor: **National Institute of Mental Health (NIMH)** · enrollment: 24 (actual)

## Conditions studied

- Neurocysticercosis
- Healthy

## Interventions

- **DRUG:** [F-18]FBR

## Key facts

- **NCT ID:** NCT00527579
- **Lead sponsor:** National Institute of Mental Health (NIMH)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09-04
- **Primary completion:** 2013-11-26
- **Final completion:** 2013-11-26
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00527579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00527579, "PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FB". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00527579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*